FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Abstract
OBJECTIVE: To assess the feasibility of positron emission tomography/magnetic resonance imaging (PET/MR) with 18F-fluordeoxyglucose (FDG) for initial staging of sarcoma.
MATERIALS AND METHODS: Twenty-nine patients with sarcoma were included in this study. Weighted kappa (κ) was used to assess the agreement between PET/MR and conventional imaging (CT and MR). The accuracy of PET/MR and conventional imaging for distant metastases was compared using receiver operating characteristic (ROC) analysis.
RESULTS: T and M stage were identical for PET/MR and conventional modalities in all patients (κ=1). N stage was identical for 28/29 patients (κ=0.65).
CONCLUSIONS: FDG PET/MR shows excellent agreement with the currently preferred imaging methods (CT and MR) in initial staging of sarcoma.
Details
Original language | English |
---|---|
Pages (from-to) | 126-132 |
Number of pages | 7 |
Journal | Clinical Imaging |
Volume | 42 |
Publication status | Published - 2017 |
Peer-reviewed | Yes |
External IDs
researchoutputwizard | legacy.publication#79504 |
---|---|
PubMed | 27951459 |
Scopus | 85002691977 |
Keywords
Keywords
- Adolescent, Adult, Aged, Bone Neoplasms/diagnostic imaging, Female, Fluorodeoxyglucose F18, Humans, Magnetic Resonance Imaging/methods, Male, Middle Aged, Multimodal Imaging/methods, Neoplasm Staging, Positron-Emission Tomography/methods, Radiopharmaceuticals, Sarcoma/diagnostic imaging, Soft Tissue Neoplasms/diagnostic imaging, Tomography, X-Ray Computed/methods, Young Adult